Second Nature (Clinics/Outpatient Services)

Website
Current Valuation
$46.5M
As of May 26, 2024
Total Funding Raised
$29.0M
Last Round
Later Stage VC

$540.0K

Last Funding
May 2024

Funding date

Capital Efficiency
1.61x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Second Nature (Clinics/Outpatient Services) is currently valued at $46.5M as of May 26, 2024. The company has raised a total of $29.0M in funding.

Capital Efficiency

With a capital efficiency ratio of 1.61x, Second Nature (Clinics/Outpatient Services) has achieved a valuation that is 1.61 times the total capital raised.

Track Second Nature (Clinics/Outpatient Services) Valuation Updates

Get notified when Second Nature (Clinics/Outpatient Services) raises new funding or valuation changes

Explore More Data
Detailed analysis for Second Nature (Clinics/Outpatient Services)

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Second Nature (Clinics/Outpatient Services)'s valuation history, funding rounds, and growth metrics.

No credit card required

What is Second Nature (Clinics/Outpatient Services) Worth in 2026?

Second Nature (Clinics/Outpatient Services) is a leading private company in the technology sector. Track Second Nature (Clinics/Outpatient Services)'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Second Nature (Clinics/Outpatient Services) Valuation is Determined

Private company valuations like Second Nature (Clinics/Outpatient Services)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.